- Home
- IVT vs NVCR Comparison
IVT vs NVCR Comparison
Compare IVT & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVT
- NVCR
- Stock Information
- Founded
- IVT 2005
- NVCR 2000
- Country
- IVT United States
- NVCR Switzerland
- Employees
- IVT N/A
- NVCR N/A
- Industry
- IVT Real Estate Investment Trusts
- NVCR Medical/Dental Instruments
- Sector
- IVT Real Estate
- NVCR Health Care
- Exchange
- IVT Nasdaq
- NVCR Nasdaq
- Market Cap
- IVT 2.3B
- NVCR 1.9B
- IPO Year
- IVT N/A
- NVCR 2015
- Fundamental
- Price
- IVT $27.47
- NVCR $15.58
- Analyst Decision
- IVT Buy
- NVCR Buy
- Analyst Count
- IVT 5
- NVCR 6
- Target Price
- IVT $31.75
- NVCR $34.17
- AVG Volume (30 Days)
- IVT 457.4K
- NVCR 736.7K
- Earning Date
- IVT 04-30-2025
- NVCR 04-24-2025
- Dividend Yield
- IVT 3.46%
- NVCR N/A
- EPS Growth
- IVT 143.52
- NVCR N/A
- EPS
- IVT 0.19
- NVCR N/A
- Revenue
- IVT $273,974,000.00
- NVCR $605,220,000.00
- Revenue This Year
- IVT $10.90
- NVCR $3.14
- Revenue Next Year
- IVT $7.68
- NVCR $10.63
- P/E Ratio
- IVT $144.58
- NVCR N/A
- Revenue Growth
- IVT 6.14
- NVCR 18.82
- 52 Week Low
- IVT $23.69
- NVCR $11.70
- 52 Week High
- IVT $31.65
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- IVT 44.91
- NVCR 34.24
- Support Level
- IVT $25.77
- NVCR $15.49
- Resistance Level
- IVT $27.54
- NVCR $17.06
- Average True Range (ATR)
- IVT 1.00
- NVCR 1.06
- MACD
- IVT -0.02
- NVCR -0.01
- Stochastic Oscillator
- IVT 48.92
- NVCR 20.42
About IVT InvenTrust Properties Corp.
InvenTrust Properties Corp is the United States of America based company qualified as a REIT (Real Estate Investment Trust). It is focused on owning, leasing, redeveloping, acquiring and managing a multi-tenant retail platform. The company's wholly-owned and managed retail properties include grocery-anchored community and neighborhood centers and power centers, including those classified as necessity-based. InvenTrust operates through a single segment i.e. multi-tenant retail.
About NVCR NovoCure Limited
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.